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ABSTRACT 
The majority of characterised ferrochelatase enzymes catalyse the final step of classical haem 
synthesis, inserting ferrous iron into protoporphyrin IX. However, for the recently-discovered 
coproporphyrin-dependent pathway, ferrochelatase catalyses the penultimate reaction where 
ferrous iron is inserted into coproporphyrin III. Ferrochelatase enzymes from the bacterial 
phyla Firmicutes and Actinobacteria have previously been shown to insert iron into 
coproporphyrin, and those from Bacillus subtilis and Staphylococcus aureus are known to be 
inhibited by elevated iron concentrations. The work herein reports a Km (coproporphyrin III) 
for S. aureus ferrochelatase of 1.5 µM and it is shown that elevating the iron concentration 
increases the Km for coproporphyrin III, providing a potential explanation for the observed 
iron-mediated substrate inhibition. Together, structural modelling, site-directed mutagenesis, 
and kinetic analyses confirm residue Glu271 as being essential for the binding of iron to the 
inhibitory regulatory site on S. aureus ferrochelatase, providing a molecular explanation for 
the observed substrate inhibition patterns. This work therefore has implications for how haem 
biosynthesis in S. aureus is regulated by iron availability. 
KEYWORDS: Coproporphyrinogen, ferrochelatase, haem biosynthesis 
SUMMARY STATEMENT: This study provides new kinetic data for the recently-identified 
haem biosynthetic enzyme, coproporphyrin ferrochelatase, from Staphylococcus aureus. In 
addition, the location of an inhibitory metal binding site is identified for the first time, which 
has important implications for how haem synthesis in bacterial pathogens is regulated by iron. 
INTRODUCTION 
Ferrochelatase enzymes catalyse the insertion of metal ions into porphyrin rings. The 
insertion of ferrous iron (Fe2+) into protoporphyrin IX is the final step in the well-
characterised classical haem synthesis pathway. However, bacterial species in the Firmicutes 
and Actinobacteria Phyla (Bacillus subtilis, Mycobacterium tuberculosis, Propionibacterium 
acnes, S. aureus) have been shown to utilise a µFRSURSRUSK\ULQ-GHSHQGHQW¶SDWKZD\ [1, 2], 
where Fe2+ insertion into coproporphyrin III is the penultimate step (Fig. 1). Branching and 
regulation of these bacterial haem biosynthetic pathways are discussed in a recent review that 
suggests a series of new abbreviations based on enzyme activities [3]. These new 
abbreviations provide a useful way of discriminating between protoporphyrin ferrochelatase 
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(PpfC) and coproporphyrin ferrochelatase (CpfC), and this nomenclature is adopted herein in 
place of the traditional HemH abbreviation. 
 Ferrochelatases are membrane-bound proteins in eukaryotes and many prokaryotes, 
but Gram-positive bacteria have been shown to encode a soluble form of the protein [4-6]. All 
of these forms of ferrochelatase have been shown to insert a variety of divalent metals into the 
centre of porphyrin molecules, with zinc being the most common metal used in in vitro assays 
due to being more stable in an aerobic environment than the natural Fe2+ substrate [7] and 
allows for fluorescence based assays to be utilised. Catalytic rates for ferrochelatases vary 
with kcat values typically ranging from 0.11 min-1 to 15.3 min-1, although S. aureus CpfC was 
recently reported to have a kcat of 165 min-1 using coproporphyrin III and Fe2+ as substrates 
[1]. Parallel experiments performed for the B. subtilis CpfC gave a kcat of 78 min-1 , which 
compares to another report of 0.11 min-1 [2]. This recent work also identified 0.8 µM as the 
threshold concentration of Fe2+ above which inhibition occurs for the B. subtilis and S. aureus 
enzymes, which represents an interesting feature unique to coproporphyrin-dependent 
ferrochelatases. 
While bacterial and mammalian ferrochelatase enzymes generally exhibit poor 
sequence identity (e.g. <10% between Human and B. subtilis), the secondary and tertiary 
structures are similar in the core region [8]. However, human and yeast PpfC enzymes have 
an extended C-terminal region compared to B. subtilis CpfC. The Human enzyme ligates a 
[2Fe-2S] iron-sulphur cluster in this region, which is not present in the S. cerevisiae enzyme. 
This cluster is ligated by one residue in the core of the protein (Cys 196) and three in the 
extended C-terminal region (Cys 403, 406, 411), and at the time was thought to be 
responsible for anchoring the extended C-terminal to the rest of the monomer, and was also 
suggested to be indirectly involved in stabilising the dimer form of the protein [8]. S. 
cerevisiae does not contain the necessary residues in the same location to form a cluster and 
the dimer stability is reportedly not affected [9]. Some ferrochelatases from Gram-positive 
bacteria have been shown to ligate [2Fe-2S] clusters via an extra insertion, although loss of 
this cluster did not result in a total loss of activity [10] in contrast to the [2Fe-2S] cluster of 
the human enzyme [11]. The in vivo role for these cofactors remains poorly understood. 
Ferrochelatase structures exhibit a degree of variability with respect to the residues 
present in the substrate binding cleft. For eukaryotic PpfC enzymes a series of leucine 
residues form part of the hydrophobic lip that covers the active site pocket, which is not 
present in the B. subtilis enzyme. The Tyr13 residue in B. subtilis CpfC, which has been 
determined to aid the conserved His183 residue in stabilisation of the B ring of the porphyrin 
macrocycle, is not present in the membrane-associated ferrochelatases [12]. The residue in 
this position in the other enzymes is a methionine whose role is not entirely understood [8, 9]. 
The tyrosine residue in B. subtilis has been implicated in a metal-binding function in the 
catalytic metal binding site along with the conserved histidine and glutamic acid residues [12, 
13] and it is possible that the methionine residue in this position aids in the insertion of metals 
into the porphyrin ring in a similar manner to the tyrosine residue found in the soluble form of 
ferrochelatase. The amino acid at this position has also been linked to the specificity of metal 
chelation, with a Y13M mutation of the B. subtilis enzyme resulting in a more rapid insertion 
of Co2+ and a complete loss of Cu2+ utilisation [14].  
Soluble ferrochelatases have been crystallised with a variety of metals present in the 
metal binding cleft, and have been shown to have two separate sites for metal binding: one 
close to the porphyrin binding site stabilised by the conserved His183 and one closer to the 
surface of the protein approximately 7Å from the H183 residue [12]. In B. subtilis CpfC, this 
outer site has been shown to bind Mg2+ ions, which are co-ordinated by the residues Arg46, 
Glu268 and Glu272 [12]. This particular metal site has been reported to provide a Mg2+-
mediated stimulation of zinc insertion into deuteroporphyrin IX, with mutation of the Glu272 
residue resulting in abolition of the stimulatory effects of Mg2+ [13]. The mechanism for this 
stimulation was proposed to be due to repulsion between metal ions present at both sites 
pushing the inserted metal at the inner (catalytic) binding site closer to the porphyrin ring 
[13]. Such a regulatory metal site has not been investigated in the human enzyme, and it 
seems unlikely that S. cerevisiae PpfC could bind metals at this site due to the presence of a 
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glycine residue instead of a glutamate residue at position 322 [9]. However, it has been 
suggested that S. cerevisiae PpfC can bind the inhibitor Cd2+ at two sites, with one site 
slightly further away from the active site than the outer metal binding site for B. subtilis 
CpfC. Human PpfC is susceptible to substrate inhibition when zinc is the metal ion substrate. 
This zinc inhibition is more pronounced at higher concentrations of the porphyrin substrate, 
suggesting that an inhibitory metal ion binds to the enzyme-product complex [15]. Residues 
that are predicted to be predominantly involved in metal binding in B. subtilis, where Zn2+ and 
Cd2+ have been observed, are the conserved residues H183 and E264 and the unique Y13 
residue that resides on the other side of the porphyrin binding site [13]. Cd2+ has been shown 
to also bind to the nearby H262, which is located underneath the porphyrin substrate and is 
proposed to inhibit CpfC by hampering the binding of porphyrin substrate [13]. 
The current work investigates the kinetic properties of CpfC from the human 
pathogen S. aureus using the native substrates Fe2+ and coproporphyrin III. Since iron has 
dramatic inhibitory properties for this class of coproprophyrin ferrochelatases [1], this study 
aims to test the hypothesis that iron inhibition is mediated by the regulatory metal binding site 
previously shown to bind Mg2+ in the B. subtilis enzyme [12, 13]. This work has implications 
for how staphylococci respond to nutritional immunity (e.g. metal sequestration) encountered 
during infection. 
 
EXPERIMENTAL PROCEDURES  
 
Cloning, overexpression, and purification of S. aureus ferrochelatase 
The cpfC (hemH) gene was amplified from S. aureus strain USA300 [16] via colony PCR 
using Q5 polymerase (NEB) and cloned into the NheI/HindIII sites of plasmid pTrcHis 
(ThermoFischer), and the correct sequence of the resultant pTrcHis-Sa-cpfC vector was 
confirmed by Sanger sequencing. E. coli JM109 cells (SigmaAldrich) were transformed with 
pTrcHis-Sa-cpfC and a 10 mL LB overnight culture of this expression strain was used to 
inoculate 1L of Circlegrow medium in a 2L baffled flask (125 µgmL-1 ampicillin was 
included throughout for plasmid selection). Cultures were grown for 24 h at 37 °C and 160 
rpm and cells were harvested (4 krpm, 4 °C, 20 min) and stored at -20 °C. Cell pellets from 1L 
cultures were re-suspended in protein storage buffer (30 mL) containing 50mM Tris/MOPS 
pH 8.0, 100mM KCl, 1% sodium cholate.  Cell suspensions were sonicated (6 x 30 s on ice at 
10 µ, with 30 s intervals between bursts), and cell debris was removed via centrifugation (18 
krpm, 4 °C, 20 min). The supernatant was applied to a column containing Talon metal affinity 
resin (2.5 mL bed volume) equilibrated with 5 column volumes of protein storage buffer. The 
column was washed with 20 column volumes of protein storage buffer followed by 5 column 
volumes of wash buffer (protein storage buffer including 15 mM imidazole), and purified 
protein was eluted with 5 column volumes of elution buffer (protein storage buffer including 
300 mM imidazole). Purified protein was concentrated to <1 mL using a 10 kDa spin 
concentrator (Millipore) and imidazole was removed using a PD10 desalting column (GE 
Healthcare) equilibrated with protein storage buffer. 
 
Assay of S. aureus ferrochelatase activity 
Purified CpfC was assayed using coproporphyrin III (Frontier Scientific) as the porphyrin 
substrate and ferrous iron as the inserted metal ion.  Coproprophyrin III powder was 
solubilised using a few drops of ammonium hydroxide and was then diluted in assay buffer 
(0.1 M Tris-HCl pH 8.1, 0.5 % sodium cholate, 0.5 % Tween 20, 1 P0ȕ-mercaptoethanol). 
Coproporphyrin III stock solutions were quantified in 0.1 M HCl spectrophotometrically 
XVLQJ DQ H[WLQFWLRQ FRHIILFLHQW RI ڙ399.5 = 489 mM-1cm-1 [17]. Ferrous iron solutions were 
quantified spectrophotRPHWULFDOO\XVLQJIHUUR]LQHVROXWLRQDQGDQH[WLQFWLRQFRHIILFLHQWRIڙ562 
= 27.9 mM-1cm-1 [18]. Iron chelation was measured using a continuous assay essentially as 
previously described [10]. Activity of 50 nM CpfC was monitored using a Cary 60 
spectrophotometer at 30 oC. The reactions were initiated by the addition of enzyme, which 
was preincubated at 30 oC, and the depletion of coproporphyrin III was monitored at 392 nm 
for 3 min (ڙ392 = 115 mM-1cm-1, [1]). All assays contained 0.1 M Tris-HCl pH 8.1, 0.5% 
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VRGLXP FKRODWH   7ZHHQ  P0 ȕ-mercaptoethanol. The steady state rates were 
estimated using linear regression of the timecourse at the start of the reaction. Michaelis plots 
(v vs. [S]) were fitted to the Michaelis Menten equation using nonlinear regression. Ki,app 
values were calculated by fitting v vs. [inhibitor] data to a single binding site model described 
by equation 1 [19], where no mechanistic assumptions are made to perform a quantitative 
assessment of the key features of inhibition: 
n
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           (1) 
where v is the enzymatic rate, vcontrol is the rate in the absence of inhibitor, vmin is the rate in the 
presence of saturating inhibitor, [I] is the inhibitor concentration, Ki,app is the apparent 
inhibition constant defining the inhibitor concentration that elicits 50 % of the total inhibition, 
and n is the Hill coefficient. 
 
 
Structural modelling of S. aureus ferrochelatase 
A structural model for S. aureus CpfC was generated using the RaptorX server [20, 21] with 
B. subtilis CpfC as a template (PDB LG $.Į-carbon RMSD = 0.23 Å). The S. aureus 
CpfC PRGHOZDVVXSHUSRVHGĮ-carbon RMSD = 0.66 Å) onto a Mg2+-bound and porphyrin-
bound structure of B. subtilis CpfC (PDBid = 1C1H), and the native substrate coproporphyrin 
III was modelled into the active site in place of N-methyl mesoporphyrin via superposition 
using CCP4MG software. 
 
RESULTS 
 
Measurement of kinetic constants for S. aureus ferrochelatase  
Since much of the previous work on coproporphyrin ferrochelatases has been performed with 
non-native substrates (i.e. Zn2+, protoporphyrin IX, deuteroporphyrin IX), it was of interest to 
define the kinetic constants for the in vivo substrates Fe2+ and coproporphyrin III. Kinetic 
assays where [Fe2+] was varied (Fig. 2A) demonstrate substrate inhibition above 0.8 µM, and 
the data below this threshold value were fitted to the Michaelis equation to provide an 
estimate of 0.27 ± 0.04 µM for an apparent Km for iron binding at the inner catalytic metal 
site. Varying [coproprophyrin III] at a fixed concentration of 0.7 µM Fe2+ (Fig. 2B) provides 
the first estimate of an apparent Km for coproprophyrin III as 1.5 ± 0.2 µM, and kcat was fitted 
as 10.5 ± 0.4 min-1 at this sub-inhibitory Fe2+ concentration. 
 
Elevated iron increases the Km for coproporphyin III 
To gain an insight into the influence of iron upon coproporphyrin III binding, kinetic plots 
were produced for each substrate at fixed concentrations of the other substrate (Fig. 3). 
Firstly, varying the [coproporphyrin III] in the presence of fixed (sub-inhibitory) 
concentrations of Fe2+ revealed that increasing [Fe2+] increases the apparent Km for 
coproporphyrin (Fig. 3A). Performing the converse experiment with variation of [Fe2+] in the 
presence of fixed concentrations of coproporphyrin III revealed a more conventional pattern 
of increasing the concentration of coproporphyrin III also decreases the apparent Km for Fe2+ 
(Fig. 3B). 
 
Structural modelling of S. aureus ferrochelatase reveals a regulatory metal binding site 
Based on the data in Fig. 3, it was hypothesized that S. aureus CpfC has a regulatory metal 
binding site, and the most simple explanation would be that this metal site is at the same 
location as the Mg2+-binding site in B. subtilis CpfC. The only difference is that that this site 
would be inhibitory when occupied by iron, as opposed to stimulatory when occupied by 
Mg2+ [13]. To investigate the local environment of this putative regulatory metal site, a 
structural model for S. aureus CpfC was generated using the B. subtilis CpfC crystal structure 
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as a template (Fig. 4). The model and template were superposed and the Mg2+ ion from the B. 
subtilis structure was shown in the same spatial location in the S. aureus model (Fig. 4A). The 
metal-binding residues were fully conserved between species, with residues Glu271, Glu267, 
and Arg45 in the S. aureus model all mapping adjacent to the outer regulatory metal site (Fig. 
4B). 
 
Magnesium potentiates Fe2+-mediated inhibition of S. aureus ferrochelatase 
Since Mg2+ has previously been used to investigate the regulatory metal site in B. subtilis 
CpfC and was shown to stimulate chelatase activity [13], it was of interest to determine if 
Mg2+ could also be used as a molecular probe to study S. aureus CpfC. To investigate the 
effect of Mg2+ upon the Fe2+ kinetics, iron was varied in the presence and absence of Mg2+ 
(Fig. 5). Surprisingly, addition of Mg2+ potentiates chelatase inhibition, lowering the 
threshold concentration of Fe2+ required for substrate inhibition. 
 
Loss of the regulatory binding site abolishes inhibition by Mg2+ or Fe2+ 
To test the hypothesis that the metal-binding site shown in Fig. 4 is involved in the Mg2+-
mediated inhibition kinetics shown in Fig. 5, Glu271 was mutated to serine and the resultant 
E271S mutant protein was purified and assayed in the presence and absence of Mg2+ (Fig. 6). 
Fig. 6A shows that Mg2+-potentiated inhibition was dramatically diminished in the E271S 
mutant, and that inhibition by Fe2+ in the absence of Mg2+ was also dramatically diminished. 
Fig. 6B displays Ki,app(Mg2+) values for wild type and E271S CpfC as 66 µM and 11 mM, 
respectively, highlighting a dramatic loss of sensitivity to Mg2+ for the mutant enzyme. 
Together, these data strongly indicate that in wild type S. aureus CpfC, the binding of Mg2+ or 
Fe2+ at this metal site results in enzyme inhibition. In addition, the data in Figures 4-6 suggest 
that loss of the inhibitory metal site should reverse the inhibitory effects of increasing iron 
concentrations seen in Fig. 3A, so a similar kinetic study was carried out with the E271S 
variant of S. aureus CpfC including iron levels well above the inhibitory threshold for the 
wild type enzyme (Fig. 7). These data confirm that loss of the E271 metal site abolishes the 
iron-mediated inhibition with respect to coproporphyrin III (Fig. 7A), and the effect of 
varying [coproporphyrin III] upon the kinetic constants for iron (Fig. 7B) remains similar to 
the wild type data (Fig. 3B). 
 
DISCUSSION 
 
Preliminary kinetic analysis of S. aureus CpfC revealed a kcat of 10.5 ± 0.4 min-1. This rate is 
comparable to previous measurements for other bacterial protoporphyrin ferrochelatases [10], 
and slightly higher than previous measurements of  1.8 min-1  and 0.11 min-1 for 
coproprophyrin ferrochelatases from M. tuberculosis and B. subtilis, respectively [2]. While a 
kcat for S. aureus CpfC was recently calculated to be 165 min-1 via extrapolation of a substrate 
inhibition curve [1], the maximum rates measured (~28 min-1) were of a similar magnitude to 
those presented herein. We report the first measurement of Kapp (coproporphyrin III) for S. 
aureus CpfC as 1.5 ± 0.2 µM, which is slightly lower than previous measurements of 10.5 
µM and 7.8 µM for CpfC enzymes from M. tuberculosis and B. subtilis, respectively [2]. Our 
estimate of 0.27 ± 0.04 µM for Kapp (Fe2+) is comparable with a previous estimate of 0.6 ± 0.1 
µM for this enzyme [1], although both of these measurements were hampered by substrate 
inhibition by iron. 
 Primary and secondary kinetic plots clearly demonstrate that elevating the iron 
concentration increases the Km for coproporphyrin III (Fig. 3A), which is consistent with Fe2+ 
causing inhibition at higher concentrations. It was therefore hypothesized that Fe2+ is inserted 
into the porphyrin substrate following binding to a well-known catalytic site adjacent to the 
tetrapyrrole substrate, and higher concentrations of Fe2+ inhibit chelation by binding at a 
second regulatory site. Structural modelling (Fig. 4) provides convincing evidence that S. 
aureus possesses a second metal binding site similar to the Mg2+-binding site in B. subtilis 
CpfC [12], although Mg2+ was found to potentiate Fe2+-mediated inhibition in the current 
study (Fig. 5) compared to having a stimulatory role in previous reports [13]. This could be 
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due to differences in substrates used, as the current study uses the native substrates whereas 
previous work has used Zn2+ and deuteroporphyrin IX as substrates [13], which could 
influence the behavior of metals in the active site. Indeed, previous measurements of S. 
aureus CpfC kinetics demonstrate a lack of Fe2+-mediated inhibition when protoporphyrin IX 
is used as a substrate [1].  
 To confirm the involvement of the regulatory metal site (Fig. 4) in allosteric 
modulation of S. aureus CpfC, the E271S mutant enzyme was purified and kinetic analyses 
were performed in the presence and absence of Mg2+. A high concentration of 4 mM Mg2+ 
was used initially to saturate metal binding (i.e. Fe2+ and Mg2+) at the inhibitory site. 
Substitution of this glutamate residue with serine resulted in two dramatic outcomes: substrate 
inhibition by Fe2+ was lost and Mg2+ was no longer a potent inhibitor of metal chelation (Fig. 
6A). This strongly suggests that the binding of Fe2+ or Mg2+ is stabilized by Glu271.  To add 
weight to this conclusion, Mg2+ dose response data confirms that Mg2+ is a potent inhibitor of 
the wild type enzyme but not the E271S mutant (Fig. 6B).  Steady state kinetics for the E271S 
mutant revealed that loss of metal binding at this residue reverses the Fe2+-mediated increase 
in Km(coproporphyrin III) (Fig. 7A) that is seen for the wild type enzyme in Fig. 3A. The 
effect of varying [coproporphyrin III] upon the kinetic constants for iron elicits the same 
pattern for the wild type (Fig. 3B) and E271S mutant (Fig. 7B), which strongly suggests that 
metal binding at the E271S site largely inhibits coproprophyrin binding and/or chelation 
rather than iron binding at the catalytic site.Taken together, all data presented herein support 
the model for wild type S. aureus CpfC in Fig. 8 where iron binding to a lower affinity 
regulatory site at E271 (blue) diminishes the rate of iron chelation at an inner catalytic site 
(green) via increasing the Km for the coproporphyrin III substrate. 
 It is well-known that there is fierce competition for iron both during infection 
resulting from nutritional immunity [22], and during growth in mixed microbial communities 
mediated by microbial siderophores. Therefore, where iron is scarce it is important for S. 
aureus to tightly regulate how this nutrient is used within the cell. The current work is 
consistent with a model whereby at very low Fe2+ concentrations ferrochelatase is able to 
insert iron into coproporphyrin III, whereas at higher iron concentrations flux through this 
step of the pathway is down-regulated. There may be a number of reasons for this substrate 
inhibition, including avoiding accumulation of Fe-coproporphyrin III, or perhaps once the 
haem requirements of the cell are satisfied Fe2+ is made available for other processes (e.g. Fe-
S cluster assembly). Future studies on bacteria that perform coproporphyrin-dependent haem 
biosynthesis are required to reveal the hierarchical channelling of iron for different uses in the 
cell, which will be important during infection (S. aureus, M. tuberculosis, P. acnes) and 
growth in microbial communities (B. subtilis). 
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FIGURE LEGENDS 
 
Figure 1. The coproporphyrin-dependent pathway of haem synthesis. This figure depicts 
a recently discovered route for haem synthesis in Firmicutes and Actinobacteria catalysed by 
coproporphyrinogen oxidase (CgoX), coproporphyrin ferrochelatase (CpfC), and coprohaem 
decarboxylase (ChdC). These new abbreviations are introduced in a recent review [3].  
 
Figure 2. Kinetic analysis of S. aureus ferrochelatase. A) 50 nM CpfC was assayed in the 
presence of varying concentrations of iron and a fixed concentration of 1 µM of 
coproporphyrin. Data collected at 0 - 0.8 µM iron were fitted to a single rectangular 
hyperbola to provide an estimate of the apparent Km for iron (Kapp = 0.27 ± 0.04). B) 50 nM 
CpfC was assayed in the presence of varying concentrations of coproprophyrin III and a fixed 
iron concentration of 0.7 µM (below the 0.8 µM inhibitory iron concentration). Data were 
fitted to a single rectangular hyperbola via nonlinear regression: kcat = 10.5 ± 0.4 min-1, Kapp = 
1.5 ± 0.2 µM. 
 
Figure 3. Opposing kinetic patterns for the two ferrochelatase substrates. Primary 
Michaelis Menten plots were generated with fixed concentrations of iron (panel A) and 
coprorporphyrin III (panel B), and data were fitted to single rectangular hyperbolae via 
nonlinear regression. Lineweaver-Burk plots (insets) are shown to highlight differences in 
kinetic patterns between panels A and B. To avoid well-known problems with these 
secondary plots, trend lines were generated using the kinetic constants obtained from 
nonlinear regression of the untransformed data. 
 
Figure 4. Structural modelling of bound coproprophyrin and a regulatory metal binding 
site for S. aureus ferrochelatase. A) Surface electrostatics view of a S. aureus CpfC 
structural model generated using the RaptorX server with B. subtilis CpfC as a template 
3'%LG $.Į-carbon RMSD = 0.23 Å). The S. aureus &SI&PRGHOZDVVXSHUSRVHGĮ-
carbon RMSD = 0.66 Å) onto a Mg2+-bound (cyan) and porphyrin-bound structure of B. 
subtilis CpfC (PDBid = 1C1H), and the native substrate coproporphyrin III (yellow) was 
modelled into the active site in place of N-methyl mesoporphyrin. B) Cartoon representation 
of the active site of S. aureus CpfC showing conserved residues implicated in metal binding 
at an outer regulatory site (E271, E267, R45) and an inner catalytic site (E263, Y12, H181).  
 
Figure 5. Impact of magnesium upon ferrochelatase kinetics. v vs. [Fe2+] plots were 
generated for  S. aureus &SI&DVVD\HG LQWKHSUHVHQFHżDQGDEVHQFHƔRIP00J2+. 
Fixed concentrations of 50 nM enzyme and 2 µM coproporphyrin III were used, with the Fe2+ 
concentration being varied. 
 
Figure 6. Loss of the metal-binding residue Glu271 abrogates the inhibition of S. aureus 
ferrochelatase by iron and magnesium. A) v vs. [Fe2+] plots were generated for  wild type 
(red) and an E271S variant of S. aureus CpfC (blue) assayed in the presence (squares) and 
absence (circles) of 4 mM Mg2+. Fixed concentrations of 50 nM enzyme and 2 µM 
coproporphyrin III were used. The fitted blue line provides estimates of apparent kinetic 
constants when the inhibition by Fe2+ is removed: kcat = 24.1 ± 2.0 min-1, Kapp(Fe2+) = 1.2 ± 0.2 
µM. B) Inhibition dose responses for wild type (red) and an E271S variant of S. aureus CpfC 
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(blue) assayed in the presence of increasing concentrations of Mg2+. Fixed concentrations of 
50 nM enzyme, 2 µM coproporphyrin III, and 0.7 µM Fe2+ were used. To estimate Ki,app 
values the data were fitted to a four parameter Hill equation (Equation 1, [19]) with the 
minimum activity (i.e. vmin) constrained to a positive value. 
 
Figure 7. Loss of inhibitory metal site restores conventional Michaelis kinetics. Primary 
Michaelis Menten plots for an E271S variant of S. aureus CpfC were generated with fixed 
concentrations of iron (panel A) and coproporphyrin III (panel B), and data were fitted to 
single rectangular hyperbolae via nonlinear regression. Lineweaver-Burk plots (insets) are 
shown to highlight differences in kinetic patterns between panels A and B. To avoid well-
known problems with these secondary plots, trend lines were generated using the kinetic 
constants obtained from nonlinear regression of the untransformed data. 
 
Figure 8. Kinetic model for iron-dependent inhibition of S. aureus ferrochelatase. 
Processes shown in blue and green depict conditions of high and low iron concentrations 
where the inhibitory regulatory site is occupied or empty, respectively. Since inhibition is 
only observed at higher iron concentrations, it is unlikely that the regulatory site would be 
occupied when the catalytic site is empty, so these intermediates are not shown. 
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